• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测瞬时表达蛋白产量:CHO和HEK293细胞中转染方法的比较

Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293.

作者信息

Porosk Ly, Nebogatova Jekaterina, Härk Heleri Heike, Vunk Birgit, Arukuusk Piret, Toots Urve, Ustav Mart, Langel Ülo, Kurrikoff Kaido

机构信息

Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.

Icosagen Cell Factory, Eerika tee 1, Õssu, 61713 Tartu, Estonia.

出版信息

Pharmaceutics. 2022 Sep 14;14(9):1949. doi: 10.3390/pharmaceutics14091949.

DOI:10.3390/pharmaceutics14091949
PMID:36145697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9505259/
Abstract

Therapeutic proteins are currently at the apex of innovation in pharmaceutical medicine. However, their industrial production is technically challenging and improved methods for transient transfection of mammalian cell cultures are necessary. We aimed to find a fast, microliter-scale transfection assay that allows the prediction of protein expression in the transient production settings. We used an array of lipid, polymeric and cell-penetrating peptide transfection reagents, and compared their performance in various high throughput transfection assays to their performance in protein (antibody) expression in professional protein-producer cell lines. First, we show that some of the most frequently used microliter-scale transfection efficacy assays fail to predict performance in the protein production in milliliter and liter scale settings. We found that CHO suspension culture post-transfection EGFP(+) population and SEAP quantitation correlate with large-scale protein production, whereas the adhesion culture assays and transfection of pLuc are non-predictive. Second, we demonstrated that cell-penetrating peptide-based transfection achieves significantly higher protein yields compared to PEI and lipoplex methods in both CHO and HEK293 producer cell lines. In this work we demonstrate a CPP-based transient protein expression approach that significantly outperformed the current industry standard workhorse method of PEI.

摘要

治疗性蛋白质目前处于药物医学创新的前沿。然而,它们的工业化生产在技术上具有挑战性,因此需要改进哺乳动物细胞培养的瞬时转染方法。我们旨在找到一种快速的微升规模转染检测方法,以预测瞬时生产环境中的蛋白质表达。我们使用了一系列脂质、聚合物和细胞穿透肽转染试剂,并在各种高通量转染检测中比较了它们的性能,以及它们在专业蛋白质生产细胞系中蛋白质(抗体)表达方面的性能。首先,我们表明,一些最常用的微升规模转染效率检测方法无法预测毫升和升规模环境中蛋白质生产的性能。我们发现,转染后CHO悬浮培养的EGFP(+)群体和SEAP定量与大规模蛋白质生产相关,而贴壁培养检测和pLuc转染则无法预测。其次,我们证明,在CHO和HEK293生产细胞系中,基于细胞穿透肽的转染与PEI和脂质体方法相比,能显著提高蛋白质产量。在这项工作中,我们展示了一种基于细胞穿透肽的瞬时蛋白质表达方法,其性能明显优于目前行业标准的主力方法——PEI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/9f9dc40b80ee/pharmaceutics-14-01949-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/3a15a5859137/pharmaceutics-14-01949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/fa4cd62cda8c/pharmaceutics-14-01949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/84e5b57bc95b/pharmaceutics-14-01949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/8ae12c8a74cf/pharmaceutics-14-01949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/9f9dc40b80ee/pharmaceutics-14-01949-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/3a15a5859137/pharmaceutics-14-01949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/fa4cd62cda8c/pharmaceutics-14-01949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/84e5b57bc95b/pharmaceutics-14-01949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/8ae12c8a74cf/pharmaceutics-14-01949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6f7/9505259/9f9dc40b80ee/pharmaceutics-14-01949-g005.jpg

相似文献

1
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293.预测瞬时表达蛋白产量:CHO和HEK293细胞中转染方法的比较
Pharmaceutics. 2022 Sep 14;14(9):1949. doi: 10.3390/pharmaceutics14091949.
2
A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.一种基于CHO GS基因敲除细胞系的用于治疗性蛋白质表达的高细胞密度瞬时转染系统:工艺开发与产品质量评估
Biotechnol Bioeng. 2015 May;112(5):977-86. doi: 10.1002/bit.25514. Epub 2015 Mar 16.
3
SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture.无血清悬浮培养中转染的哺乳动物细胞中海马涎酸结合蛋白的表达。
Cytotechnology. 2003 May;42(1):47-55. doi: 10.1023/A:1026125016602.
4
A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.一种高密度CHO-S瞬时转染系统:ExpiCHO和Expi293的比较。
Protein Expr Purif. 2017 Jun;134:38-46. doi: 10.1016/j.pep.2017.03.018. Epub 2017 Mar 23.
5
High-level protein expression in scalable CHO transient transfection.可扩展的中国仓鼠卵巢细胞瞬时转染中的高水平蛋白质表达
Biotechnol Bioeng. 2009 Jun 15;103(3):542-51. doi: 10.1002/bit.22265.
6
Optimal conditions for freezing CHO-S and HEK293-EBNA cell lines: influence of Me2SO, freeze density, and PEI-mediated transfection on revitalization and growth of cells, and expression of recombinant protein.冷冻CHO-S和HEK293-EBNA细胞系的最佳条件:二甲基亚砜、冷冻密度以及聚乙烯亚胺介导的转染对细胞复苏、生长及重组蛋白表达的影响
Biotechnol Bioeng. 2008 Aug 1;100(5):911-22. doi: 10.1002/bit.21832.
7
High Throughput Transfection of HEK293 Cells for Transient Protein Production.用于瞬时蛋白表达的HEK293细胞的高通量转染
Methods Mol Biol. 2018;1850:179-187. doi: 10.1007/978-1-4939-8730-6_12.
8
Optimisation of a simple method to transiently transfect a CHO cell line in high-throughput and at large scale.一种用于高通量大规模瞬时转染CHO细胞系的简单方法的优化。
Protein Expr Purif. 2015 Dec;116:113-9. doi: 10.1016/j.pep.2015.08.016. Epub 2015 Aug 17.
9
Enhancement of DNA uptake in FUT8-deleted CHO cells for transient production of afucosylated antibodies.增强 FUT8 缺失 CHO 细胞的 DNA 摄取,用于瞬时生产去岩藻糖基化抗体。
Biotechnol Bioeng. 2010 Aug 1;106(5):751-63. doi: 10.1002/bit.22749.
10
A BioDesign Approach to Obtain High Yields of Biosimilars by Anti-apoptotic Cell Engineering: a Case Study to Increase the Production Yield of Anti-TNF Alpha Producing Recombinant CHO Cells.一种通过抗细胞凋亡细胞工程获得高生物类似物产量的生物设计方法:以提高抗 TNF-α 产生的重组 CHO 细胞产量为例。
Appl Biochem Biotechnol. 2018 Jan;184(1):303-322. doi: 10.1007/s12010-017-2540-2. Epub 2017 Jul 6.

引用本文的文献

1
Boosting Lipofection Efficiency Through Enhanced Membrane Fusion Mechanisms.通过增强膜融合机制提高脂质转染效率。
Int J Mol Sci. 2024 Dec 18;25(24):13540. doi: 10.3390/ijms252413540.
2
Enhancing Cellular Uptake of Native Proteins through Bio-Orthogonal Conjugation with Chemically Synthesized Cell-Penetrating Peptides.通过与化学合成的细胞穿透肽进行生物正交共轭增强天然蛋白质的细胞摄取。
Pharmaceutics. 2024 May 3;16(5):617. doi: 10.3390/pharmaceutics16050617.
3
A Method for Using Cell-Penetrating Peptides for Loading Plasmid DNA into Secreted Extracellular Vesicles.

本文引用的文献

1
Current state of the art in peptide-based gene delivery.基于肽的基因传递的最新技术进展。
J Control Release. 2022 Mar;343:600-619. doi: 10.1016/j.jconrel.2022.02.010. Epub 2022 Feb 11.
2
Top product forecasts for 2022.2022年热门产品预测。
Nat Rev Drug Discov. 2022 Jan;21(1):11. doi: 10.1038/d41573-021-00211-7.
3
Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes.通过修饰特定基因的表达来影响 HEK293 细胞的生长和生产性能。
一种利用穿膜肽将质粒 DNA 载入分泌型细胞外囊泡的方法。
Biomolecules. 2023 Dec 6;13(12):1751. doi: 10.3390/biom13121751.
4
Bioactivity of recombinant humanized monoclonal antibody against HER2 and and its mechanism of action in ovarian cancer.重组人源化抗HER2单克隆抗体在卵巢癌中的生物活性及其作用机制
Transl Cancer Res. 2023 Jun 30;12(6):1565-1576. doi: 10.21037/tcr-23-432. Epub 2023 Jun 19.
5
The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue.用于在脾脏组织中高效且选择性地进行mRNA体内表达的细胞穿透肽的研发
Pharmaceutics. 2023 Mar 15;15(3):952. doi: 10.3390/pharmaceutics15030952.
6
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications.细胞穿透肽NickFect55中连接子氨基酸的修饰可增强体内应用的质粒DNA转染效果。
Pharmaceutics. 2023 Mar 9;15(3):883. doi: 10.3390/pharmaceutics15030883.
7
Approaches for evaluation of novel CPP-based cargo delivery systems.基于细胞穿透肽的新型药物递送系统的评估方法。
Front Pharmacol. 2022 Oct 21;13:1056467. doi: 10.3389/fphar.2022.1056467. eCollection 2022.
Cells. 2021 Jul 2;10(7):1667. doi: 10.3390/cells10071667.
4
NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation.尼克肽类细胞穿透肽在递送至树突状细胞和皮肤炎症过程中增强 miRNA-146a 的效率。
Biomaterials. 2020 Dec;262:120316. doi: 10.1016/j.biomaterials.2020.120316. Epub 2020 Aug 29.
5
A decade of immune-checkpoint inhibitors in cancer therapy.免疫检查点抑制剂在癌症治疗中的十年。
Nat Commun. 2020 Jul 30;11(1):3801. doi: 10.1038/s41467-020-17670-y.
6
Developing therapeutic monoclonal antibodies at pandemic pace.以大流行的速度开发治疗性单克隆抗体。
Nat Biotechnol. 2020 May;38(5):540-545. doi: 10.1038/s41587-020-0512-5.
7
Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!非病毒体外基因递送:现在是提高标准的时候了!
Pharmaceutics. 2020 Feb 21;12(2):183. doi: 10.3390/pharmaceutics12020183.
8
Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP.通过优化 CPP 中的脂肪酸长度和组氨酸含量来增强 siRNA 的转染
Biomater Sci. 2019 Sep 24;7(10):4363-4374. doi: 10.1039/c9bm00688e.
9
Recombinant Antibody Production in CHO and NS0 Cells: Differences and Similarities.CHO 细胞和 NS0 细胞中的重组抗体生产:差异与相似。
BioDrugs. 2018 Dec;32(6):571-584. doi: 10.1007/s40259-018-0319-9.
10
Optimization of Protein Expression in Mammalian Cells.哺乳动物细胞中蛋白质表达的优化
Curr Protoc Protein Sci. 2019 Feb;95(1):e77. doi: 10.1002/cpps.77. Epub 2018 Sep 28.